---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-055537"
form_type: "8-K"
ticker: "XRN"
cik: "0001533615"
company_name: "Chiron Real Estate Inc."
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T01:02:44.060363+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Global Medical REIT Q1 net income $0.7M ($0.01/shr); FFO $15.1M ($0.22/shr); revenue $36.2M (+13.7% YoY)

## Summary
- Net income $0.7M ($0.01 diluted EPS) vs $2.7M ($0.04) YoY; FFO $15.1M ($0.22/shr) vs $16.0M ($0.23); AFFO $16.0M ($0.23) vs $16.8M ($0.24).
- Rental revenue $36.2M (+13.7% YoY) driven by acquisitions; portfolio leased occupancy 97.0% (up from 96.5% Dec 2022).
- Sold Jacksonville MOB for $4.4M (gain $0.5M); completed $6.7M Redding, CA acquisition on April 17 funded by OP Units at $11.00/unit.
- Dividend $0.21/shr common payable April 11; leverage 47.4%; weighted avg interest rate 4.28%; $244.5M undrawn credit facility.
- No shares issued under ATM in Q1 2023.

## SEC filing metadata
- accession: 0001104659-23-055537
- form_type: 8-K
- ticker: XRN
- cik: 0001533615
- company_name: Chiron Real Estate Inc.
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533615/000110465923055537/0001104659-23-055537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533615/000110465923055537/tm2314577d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-055537
- JSON: https://secwatch.observer/filing/0001104659-23-055537.json
- Plain text: https://secwatch.observer/filing/0001104659-23-055537.txt

## Key facts
- Earnings Releases
  Chiron Real Estate Inc. reported the three months ended March 31, 2023 results: revenue $36.2 million, net income $0.7 million, EPS $0.01 per diluted share.
  - Period: the three months ended March 31, 2023
  - Revenue: $36.2 million
  - Net income: $0.7 million
  - EPS: $0.01 per diluted share
  - Result: reported results
  source text: or $0.23 per share and unit, as compared to $16.8 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 13.7% year-over-year to $36.2 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. · Sold a medical office building located in Jacksonville, Florida, receiving gross
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533615/000110465923055537/0001104659-23-055537-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.